GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (NAS:ONVO) » Definitions » FCF Yield %

Organovo Holdings (Organovo Holdings) FCF Yield % : -137.88 (As of Apr. 30, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Organovo Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Organovo Holdings's Trailing 12-Month Free Cash Flow is $-16.92 Mil, and Market Cap is $12.27 Mil. Therefore, Organovo Holdings's FCF Yield % for today is -137.88%.

The historical rank and industry rank for Organovo Holdings's FCF Yield % or its related term are showing as below:

ONVO' s FCF Yield % Range Over the Past 10 Years
Min: -206.24   Med: -18.44   Max: -1.26
Current: -137.88


During the past 12 years, the highest FCF Yield % of Organovo Holdings was -1.26%. The lowest was -206.24%. And the median was -18.44%.

ONVO's FCF Yield % is ranked worse than
90.01% of 1551 companies
in the Biotechnology industry
Industry Median: -15.06 vs ONVO: -137.88

Organovo Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was -70,440.00%.


Organovo Holdings FCF Yield % Historical Data

The historical data trend for Organovo Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings FCF Yield % Chart

Organovo Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.63 -27.80 -16.42 -27.06 -67.07

Organovo Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.43 -102.57 -144.59 -116.56 -129.00

Competitive Comparison of Organovo Holdings's FCF Yield %

For the Biotechnology subindustry, Organovo Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organovo Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Organovo Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Organovo Holdings's FCF Yield % falls into.



Organovo Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Organovo Holdings's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-12.804 / 19.0900329
=-67.07%

Organovo Holdings's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.522 * 4 / 10.9210236
=-129.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organovo Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Organovo Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Organovo Holdings (Organovo Holdings) Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Executives
David Gobel director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Vaidehi Joshi director C/O ORGANOVO HOLDINGS, INC., 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO CA 92121
Alison Tjosvold Milhous director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Adam K Stern director STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019
Thomas Hess officer: President, CFO and PFO 366 MADISON AVE. 12TH FLOOR, NEW YORK NY 10017
Douglas Jay Cohen director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Thomas E Jurgensen officer: General Counsel & Secretary 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Jeffrey N. Miner officer: Chief Scientific Officer 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Chris Heberlig officer: President and CFO C/O KINIKSA PHARMACEUTICALS, LTD., CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON D0 HM11
Keith Murphy director, officer: Executive Chairman 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Steven George Hughes officer: Chief Medical Officer 6275 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Carolyn Beaver director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
David Shapiro director C/O INTERCEPT PHARMACEUTICALS, INC., 18 DESBROSSES ST., NEW YORK NY 10013
Presnell Sharon Collins officer: EVP, Research & Development 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Taylor Crouch director, officer: CEO & President 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075

Organovo Holdings (Organovo Holdings) Headlines

From GuruFocus

Organovo Achieves 3D Tissue Model for Crohn's Disease

By GuruFocusNews GuruFocusNews 05-27-2022

Organovo Achieves 3D Tissue Model for Crohn's Disease

By GuruFocusNews GuruFocusNews 05-17-2022

Organovo Announces One-for-Twenty Reverse Stock Split

By Marketwired Marketwired 08-17-2020

Organovo Achieves 3D Tissue Model for Crohn's Disease

By GuruFocusNews GuruFocusNews 06-26-2022

Organovo Announces FXR Program

By sperokesalga sperokesalga 03-21-2023